Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease
Objective: To characterize life course sleep duration trajectories and examine their associations with PD risk and age at onset (AAO). Background: Sleep disturbances could be…Subthalamic versus Pallidal Temporal Interference Stimulation in Parkinson’s Disease: A Pilot Study
Objective: To investigate whether transcranial temporal interference stimulation (tTIS) targeting different deep brain regions produces symptom-specific improvements consistent with established deep brain stimulation (DBS) outcomes…Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease
Objective: To study the utilization of healthcare and deep brain stimulation (DBS) in large populations of Black and White patients with Parkinson’s disease (PD). Background:…Seasonal Variations in Emergency Department Admissions Among Parkinson’s Disease Patients: A North-South Comparative Analysis
Objective: We aim to compare the effect of ambient temperature on Emergency Department (ED) admissions among Parkinson’s Disease (PD) patients in extreme and regular temperatures…Multidisciplinary Approaches to Palliative Care in Late-Stage Parkinson’s Disease: A Review of Educational Tools and Frameworks
Objective: To evaluate multidisciplinary approaches to palliative care in late-stage Parkinson’s disease (PD) and assess the effectiveness of educational tools and frameworks in improving patient…Clinical analysis of sarcopenia prevalence and its influencing factors in patients with Parkinson’s disease
Objective: In this study, we examined the prevalence of sarcopenia in patients with Parkinson's disease (PD) and the factors affecting sarcopenia in patients with PD,…Muscle Coactivation in subjects with Parkinson’s Disease: a Healthy-matched analysis of the Sub-Phases of Gait Cycle
Objective: To compare lower limb muscle coactivation (MC) during gait between Parkinson’s disease (PD) and healthy controls (HC). Background: MC increases with aging as a…Parkinson’s Disease: Increased Presence of Neuropsychiatric Symptoms and Non-Motor Issues Drive Higher Medication Use and Costs
Objective: To compare neuropsychiatric disorders (NPsy), other non-motor symptoms (NMS), and associated medication use and costs in individuals with advanced Parkinson’s Disease (aPD) with those…Split tablet dosing of Levodopa/Carbidopa/Entacapone 100mg/25mg/200mg in treating Chinese patients with early Parkinson’s disease: a single-center, prospective cohort study
Objective: To investigate split tablet dosing of Levodopa/Carbidopa/Entacapone (LCE) 100mg/25mg/200mg in treating Chinese patients with early Parkinson’s disease (PD). Background: LCE is a treatment option…Alterations of Plasma Membrane in Parkinson’s disease LRRK2 I1371V iPSC derived Astrocytes contribute to the vulnerability of the niche cells to Extracellular α-Synuclein
Objective: This study investigates the impact of LRRK2 I1371V mutation on astrocyte plasma membrane dynamics & its association with extracellular α-synuclein using astrocytes derived from…
- « Previous Page
- 1
- …
- 86
- 87
- 88
- 89
- 90
- …
- 181
- Next Page »